Biogen Inc.
Long
Updated

Buy Biogen on Fundamentals. Target $375 for 2017

88
I´ll make it simple.
1) Really promising reseachs on Alzheimer drug.
2) Atm there are 9.9MILLION new diagnoses of demencia every year(increasing market) this number is 30% more than what the worlds health organization predicted in 2010... hense the undervalue.
3) Increasing Profits
4) EPS at 4,71 higher than what many predicted.
5) Good administration.
Note
hence"

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.